TrialLipids in health and disease2024

Silymarin decreases liver stiffness associated with gut microbiota in patients with metabolic dysfunction-associated steatotic liver disease: a randomized, double-blind, placebo-controlled trial.

Yufeng Jin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.